Stocksigma LogoStocksigma Logo

Aspira Pathlab & Diagnostics Schedules Board Meeting for Q2 FY27 Results

Aspira Pathlab & Diagnostics Limited announced that its Board of Directors will meet on 6th Nov'26 to consider and approve the un-audited standalone

Aspira Pathlab & Diagnostics Schedules Board Meeting for Q2 FY27 Results

Aspira Pathlab & Diagnostics Ltd 路 Intimation 路 06 Nov 2026, 5:30 am

Aspira Pathlab & Diagnostics Schedules Board Meeting for Q2 FY27 Results Aspira Pathlab & Diagnostics Limited announced that its Board of Directors will meet on 6th Nov'26 to consider and approve the un-audited standalone financial results, alongside the limited review report, for the second quarter and half-year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company securities remains closed for designated persons and their immediate relatives until 48 hours following the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Aspira Pathlab & Diagnostics Ltd

All Aspira Pathlab & Diagnostics Ltd announcements